Company / SG&A Expense
HealthLynked Corp SG&A Expense History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$3.0M
FY2024
5-year range
$3.0M / $4.9M
FY2020-FY2024
Trend
-16.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has declined for 3 consecutive years, from $5M in FY2021 to $3M in FY2024.
Based on SEC 10-K filings.
$3M in FY2024 with a 3-year CAGR of -14.9%.
Improved from $5M to $3M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -14.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- HealthLynked Corp's sg&a expense has declined for 3 consecutive years.
- 3-year CAGR of -14.9%, indicating a declining trend.
- In FY2024, sg&a expense decreased 16.1% year-over-year.
- Peak sg&a expense was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -24.77 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $3.0M | -16.1% |
| FY2023 | $3.6M | -20.8% |
| FY2022 | $4.6M | -7.1% |
| FY2021 | $4.9M | +60.9% |
| FY2020 | $3.1M | - |